American Century Companies Inc. Purchases 284,130 Shares of The Chemours Company $CC

Key Points

• American Century Companies Inc. increased its stake in The Chemours Company by 17.5%, owning approximately $25.83 million worth of shares after acquiring an additional 284,130 shares in the first quarter.
• The company recently declared a quarterly dividend of $0.0875 per share, yielding 2.3%, with a negative dividend payout ratio of -12.50%.
• Analysts have mixed opinions, with a consensus rating of "Moderate Buy" and a price target averaging $17.38, as some firms have cut their target prices while others remain optimistic.

American Century Companies Inc. lifted its holdings in The Chemours Company (NYSE:CC - Free Report) by 17.5% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 1,909,149 shares of the specialty chemicals company's stock after purchasing an additional 284,130 shares during the quarter. American Century Companies Inc. owned about 1.28% of Chemours worth $25,831,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. SG Americas Securities LLC acquired a new position in shares of Chemours in the 1st quarter valued at approximately $822,000. Principal Financial Group Inc. lifted its stake in Chemours by 116.3% in the 1st quarter. Principal Financial Group Inc. now owns 742,119 shares of the specialty chemicals company's stock valued at $10,041,000 after acquiring an additional 399,097 shares in the last quarter. Janney Montgomery Scott LLC boosted its position in Chemours by 22.4% during the 1st quarter. Janney Montgomery Scott LLC now owns 31,886 shares of the specialty chemicals company's stock worth $431,000 after acquiring an additional 5,843 shares during the last quarter. GAMMA Investing LLC boosted its position in Chemours by 1,115.2% during the 1st quarter. GAMMA Investing LLC now owns 18,617 shares of the specialty chemicals company's stock worth $252,000 after acquiring an additional 17,085 shares during the last quarter. Finally, Bessemer Group Inc. boosted its position in Chemours by 8.7% during the 1st quarter. Bessemer Group Inc. now owns 38,554 shares of the specialty chemicals company's stock worth $522,000 after acquiring an additional 3,081 shares during the last quarter. 76.26% of the stock is currently owned by institutional investors and hedge funds.

Chemours Stock Down 2.0%

Shares of Chemours stock traded down $0.30 on Thursday, reaching $14.93. 292,599 shares of the company were exchanged, compared to its average volume of 3,540,709. The Chemours Company has a one year low of $9.13 and a one year high of $22.38. The company has a market capitalization of $2.24 billion, a price-to-earnings ratio of -5.34 and a beta of 1.61. The company has a current ratio of 1.68, a quick ratio of 0.83 and a debt-to-equity ratio of 17.16. The company has a 50-day moving average of $13.16 and a 200 day moving average of $12.89.

Chemours (NYSE:CC - Get Free Report) last posted its quarterly earnings results on Tuesday, August 5th. The specialty chemicals company reported $0.58 earnings per share for the quarter, beating analysts' consensus estimates of $0.46 by $0.12. Chemours had a positive return on equity of 35.14% and a negative net margin of 7.19%.The business had revenue of $1.62 billion for the quarter, compared to analysts' expectations of $1.57 billion. During the same quarter in the prior year, the business earned $0.38 EPS. The firm's revenue for the quarter was up 5.0% on a year-over-year basis. Chemours has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. On average, equities research analysts forecast that The Chemours Company will post 2.03 earnings per share for the current year.

Chemours Cuts Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, September 12th. Investors of record on Friday, August 15th will be paid a $0.0875 dividend. This represents a $0.35 dividend on an annualized basis and a yield of 2.3%. The ex-dividend date is Friday, August 15th. Chemours's dividend payout ratio is -12.50%.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on CC shares. Barclays reduced their price target on Chemours from $16.00 to $13.00 and set an "equal weight" rating for the company in a research report on Wednesday, May 28th. The Goldman Sachs Group reduced their price target on Chemours from $21.00 to $14.00 and set a "neutral" rating for the company in a research report on Wednesday, May 14th. UBS Group reduced their price target on Chemours from $18.00 to $17.00 and set a "buy" rating for the company in a research report on Wednesday, May 7th. Royal Bank Of Canada upped their price target on Chemours from $14.00 to $15.00 and gave the stock an "outperform" rating in a research report on Thursday, July 3rd. Finally, Morgan Stanley reduced their price target on Chemours from $22.00 to $15.00 and set an "equal weight" rating for the company in a research report on Monday, May 12th. Five investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, Chemours has an average rating of "Moderate Buy" and an average target price of $17.38.

Insiders Place Their Bets

In other Chemours news, CEO Denise Dignam purchased 4,068 shares of the company's stock in a transaction that occurred on Friday, August 8th. The shares were acquired at an average price of $12.06 per share, for a total transaction of $49,060.08. Following the purchase, the chief executive officer owned 191,546 shares in the company, valued at approximately $2,310,044.76. The trade was a 2.17% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link. Also, insider Damian Gumpel purchased 7,822 shares of the company's stock in a transaction that occurred on Tuesday, June 3rd. The stock was acquired at an average price of $9.95 per share, for a total transaction of $77,828.90. Following the purchase, the insider owned 131,701 shares in the company, valued at $1,310,424.95. This trade represents a 6.31% increase in their position. The disclosure for this purchase can be found here. In the last 90 days, insiders purchased 25,290 shares of company stock worth $250,437. 0.47% of the stock is owned by company insiders.

Chemours Company Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.